Kibow Biotech Brings Renadyl to Canada
Kibow Biotech, recognized as a pioneer in probiotic dietary supplements aimed at enhancing kidney health, has recently announced a significant development: the launch of their flagship product, Renadyl, in Canada. This milestone comes as part of the company's ongoing commitment to providing innovative and scientifically-supported solutions for those seeking to maintain their kidney health.
Renadyl, created through extensive research on the interplay between gut health and kidney function, stands out as a patented probiotic supplement that has been clinically tested to support kidney health. The formulation focuses on optimizing the gut microbiome, which plays a vital role in managing waste compounds that can increase the workload on the kidneys.
Mike Kane, President of Kibow Biotech, expressed his enthusiasm about this expansion, stating, "Bringing Renadyl to Canada marks a thrilling advancement in our mission to ensure that more individuals can access groundbreaking kidney health solutions. Since our inception in 1997, we have dedicated ourselves to advancing the understanding of the gut-kidney connection and creating products that empower individuals to proactively manage their kidney health. We are delighted to offer Renadyl to Canadian consumers seeking additional means to enhance their kidney health."
The presence of Chronic Kidney Disease (CKD) affects millions globally, underscoring the need for complementary strategies to traditional kidney care. Renadyl offers a unique gut-centric approach, leveraging specific probiotic strains to assist in the metabolism of certain waste compounds found in the intestine, ultimately contributing to better kidney function.
James Fabin, a kidney health advocate and founder of Dadvice TV, celebrates the expansion of Renadyl as a valuable resource for individuals managing CKD: "For those living with CKD, the chance to take a more active role in their kidney care is crucial. The availability of products like Renadyl widens the options for patients, empowering them to engage in informed discussions with their healthcare professionals."
Each serving of Renadyl consists of a proprietary mixture of three selected probiotic strains that deliver an impressive 45 billion colony-forming units (CFUs). These beneficial bacteria are specifically designed to thrive within the intestines, supporting the body's natural mechanisms for handling specific waste products while fostering a healthy gut environment.
Kibow Biotech’s introduction of Renadyl in Canada marks a furtherance of its enduring commitment to scientific research, product innovation, and education about the crucial link between gut health and kidney function.
Canadians can now purchase Renadyl directly at
Renadyl.ca, where they can explore the product, learn more about its benefits, and understand how it works in conjunction with existing health strategies.
About Kibow Biotech, LLC
Founded in 1997 in Philadelphia, PA, Kibow Biotech strives to deliver affordable, accessible nutritional supplements that support kidney health and various healthcare needs. The company prides itself on its thorough scientific research and clinical data, which have been published in reputable scientific and medical journals. Renadyl continues to be a key product in Kibow Biotech's mission to enhance kidney health globally.
For further information, media can reach out to:
Michelle Adams
President
PRISM Marketing
Phone: 614-989-6373
Email: [email protected]